ARCHIVES

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

This article is from The Cancer Letter archive.

Vol. 09 No. 01 | January 7, 1983

Download PDF Visit The Full Archive

Related Articles

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013

ASSIST evaluation finds proven methods help states fight tobacco.

December 5, 2003

OSI Underestimated Magnitude Of Gallo Case: Hadley

February 3, 1995

IL13-PE38 Looks Promising In Early Tests Against Gioma

September 27, 2002

DCBD Board Approves Concept for Astrocytoma Molecular Probes

July 22, 1988

Clinical Trial System Inefficient, UPCI Director Tells Senate

June 7, 2002